Amneal Pharmaceuticals ( NASDAQ:AMRX ) has announced a $270 million settlement to settle claims related to its alleged contribution to the opioid crisis in the U.S. The agreement, payable over a decade, aims to address a substantial portion of the more than 900 opioid-related lawsuits facing the company. State attorneys general have accused Amneal ( NASDAQ:AMRX )...
